Last reviewed · How we verify
Administration of ceralasertib — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Administration of ceralasertib (Administration of ceralasertib) — AstraZeneca.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Administration of ceralasertib TARGET | Administration of ceralasertib | AstraZeneca | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Administration of ceralasertib CI watch — RSS
- Administration of ceralasertib CI watch — Atom
- Administration of ceralasertib CI watch — JSON
- Administration of ceralasertib alone — RSS
Cite this brief
Drug Landscape (2026). Administration of ceralasertib — Competitive Intelligence Brief. https://druglandscape.com/ci/administration-of-ceralasertib. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab